The lung in rheumatoid arthritis, cause or consequence?

Current Opinion in Rheumatology

Volumn 28, Issue 1, 2016, Pages 76-82

  Chatzidionisyou, Aikaterini ^a   Catrina, Anca I ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anticitrullinated protein antibodies; Lungs; Rheumatoid arthritis; Rheumatoid factor

Indexed keywords

RHEUMATOID FACTOR;

ANTIBODY PRODUCTION; ANTIGENICITY; BACTERIAL PNEUMONIA; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DYSPNEA; EMPHYSEMA; FIBROSING ALVEOLITIS; GERMINAL CENTER; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HOMEOSTASIS; HUMAN; IMMUNOSTIMULATION; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; JOINT; LUNG; LUNG DISEASE; LUNG FIBROSIS; MIXED CONNECTIVE TISSUE DISEASE; MUCOSA INFLAMMATION; PLEURA DISEASE; PLEURA EFFUSION; PLEURA THICKENING; PLEURISY; PNEUMOCONIOSIS; PNEUMOTHORAX; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; RISK FACTOR; SPUTUM; VENOUS THROMBOEMBOLISM; VIRUS PNEUMONIA; COMPLICATION; IMMUNOLOGY;

ARTHRITIS, RHEUMATOID; HUMANS; LUNG; LUNG DISEASES;

EID: 84948702679     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000238     Document Type: Review

References (66)

1. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-324.
2. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League against rheumatism collaborative initiative. Ann Rheum Dis 2010; 69:1580-1588.
3. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54:38-46.
4. Turesson C, O'Fallon WM, Crowson CS, et al. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002; 29: 62-67.
5. Kelly C, Hamilton J. What kills patients with rheumatoid arthritis? Rheumatology (oxford) 2007; 46:183-184.
6. Young A, Koduri G, Batley M, et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology (oxford) 2007; 46:350-357.
7. Holt PG, Strickland DH, Wikström ME, Jahnsen FL. Regulation of immuno-logical homeostasis in the respiratory tract. Nat Rev Immunol 2008; 8: 142-152.
8. Lund FE, Hollifield M, Schuer K, et al. B cells are required for generation of protective effector and memory CD4 cells in response to pneumocystis lung infection. J Immunol 2006; 176:6147-6154.
9. Carragher DM, Rangel-Moreno J, Randall TD. Ectopic lymphoid tissues and local immunity. Semin Immunol 2008; 20:26-42.
10. Randall TD, Carragher DM, Rangel-Moreno J. Development of secondary lymphoid organs. Annu Rev Immunol 2008; 26:627-650.
11. Moyron-Quiroz JE, Rangel-Moreno J, Kusser K, et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat Med 2004; 10:927-934.
12. Snider GL, Stone PJ, Lucey EC, et al. Eglin-c, a polypeptide derived from the medicinal leech, prevents human neutrophil elastase-induced emphysema and bronchial secretory cell metaplasia in the hamster. Am Rev Respir Dis 1985; 132:1155-1161.
13. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011; 365:1567-1575.
14. Leslie KO, Trahan S, Gruden J. Pulmonary pathology of the rheumatic diseases. Semin Respir Critical Care Med 2007; 28:369-378.
15. Schneider F, Gruden J, Tazelaar HD, Leslie K. Pleuropulmonary pathology in patients with rheumatic disease. Arch Pathol Lab Med 2012; 136:1242-1252.
16. Mori S, Cho I, Koga Y, et al. Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 2008; 35:1513-1521.
17. Bilgici A, Ulusoy H, Kuru O, et al. Pulmonary involvement in rheumatoid arthritis. Rheumatol Int 2005; 25:429-435.
18. Geddes DM, Webley M, Emerson PA. Airways obstruction in rheumatoid arthritis. Ann Rheum Dis 1979; 38:222-225.
19. Kochbati S, Boussema F, Ben Miled M, et al. Bronchiectasis in rheumatoid arthritis. High resolution computed pulmonary tomography. Tunis Med 2003; 81:768-773.
20. Lake F, Proudman S.Rheumatoid arthritis and lung disease: from mechanisms to a practical approach. Semin Respir Crit Care Med 2014; 35:222-238.
21. Quirke AM, Perry E, Cartwright A, et al. Bronchiectasis: A model for chronic bacterial infection inducing autoimmunity in rheumatoid arthritis. Arthritis Rheumatol 2015; 67:2335-2342.
22. Shen TC, Lin CL, Chen CH, et al. Increased risk of chronic obstructive pulmonary disease in patients with rheumatoid arthritis: a population-based cohort study. QJM 2014; 107:537-543.
23. Hassan WU, Keaney NP, Holland CD, et al. High resolution computed tomography of the lung in lifelong nonsmoking patients with rheumatoid arthritis. Ann Rheum Dis 1995; 54:308-310.
24. Wilsher M, Voight L, Milne D, et al. Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis. Respir Med 2012; 106:1441-1446.
25. Mori S, Koga Y, Sugimoto M. Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis. Respir Med 2012; 106:1591-1599.
26. Mori S, Cho I, Koga Y, Sugimoto M. Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. J Rheumatol 2008; 35:1513-1521.
27. Yousem SA, Colby TV, Carrington CB. Lung biopsy in rheumatoid arthritis. Am Rev of Respiratory Dis 1985; 131:770-777.
28. Turesson C, Matteson EL, Colby TV, et al. Increased CD4\+ T cell infiltrates in rheumatoid arthritis-associated interstitial pneumonitis compared with idiopathic interstitial pneumonitis. Arthritis Rheum 2005; 52: 73-79.
29. Hakala M, Pääkkö P, Huhti E, et al. Open lung biopsy of patients with rheumatoid arthritis. Clin Rheumatol 1990; 9:452-460.
30. Atkins SR, Turesson C, Myers JL, et al. Morphologic and quantitative assessment of CD20\+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia. Arthritis Rheum 2006; 54:635-641.
31. Song JW, Do KH, Kim MY, et al. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest 2009; 136:23-30.
32. Kono M, Nakamura Y, Enomoto N, et al. Usual interstitial pneumonia preceding collagen vascular disease: a retrospective case control study of patients initially diagnosed with idiopathic pulmonary fibrosis. PloS One 2014; 9:e94775.
33. Sathi N, Urwin T, Desmond S, et al. Patients with limited rheumatoid arthritis-related interstitial lung disease have a better prognosis than those with extensive disease. Rheumatology (oxford) 2011; 50:620.
34. Restrepo JF, Del Rincón I, Battafarano DF, et al. Clinical and laboratory factors associated with interstitial lung disease in rheumatoid arthritis. Clin Rheumatol 2015; 34:1529-1536.
35. Koduri G, Norton S, Young A, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology (oxford) 2010; 49:1483-1489.
36. Schernthaner G, Scherak O, Kolarz G, et al. Seropositive rheumatoid arthritis associated with decreased diffusion capacity of the lung. Ann Rheum Dis 1976; 35:258-262.
37. Kelly CA, Saravanan V, Nisar M, et al. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radio logical characteristics: a large multicentre UK study. Rheumatology (oxford) 2014; 53:1676-1682.
38. Hakala M, Ruuska P, Hameenkorpi R, et al. Diffuse interstitial lung disease in rheumatoid arthritis. Views on immunological and HLA findings. Scand J Rheumatol 1986; 15:368-376.
39. DeHoratius RJ, Williams RC Jr. Rheumatoid factor accentuation of pulmonary lesions associated with experimental diffuse proliferative lung disease. Arthritis Rheum 1972; 15:293-301.
40. Giles JT, Danoff SK, Sokolove J, et al. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease. Ann Rheumatic Dis 2014; 73:1487-1494.
41. Harlow L, Rosas IO, Gochuico BR, et al. Identification of citrullinated hsp90 isoforms as novel autoantigens in rheumatoid arthritis-associated interstitial lung disease. Arthritis Rheum 2013; 65:869-879.
42. Alexiou I, Germenis A, Koutroumpas A, et al. Anticyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis. Clin Rheumatol 2008; 27:511-513.
43. Sato A, Hayakawa H, Uchiyama H, Chida K. Cellular distribution of bronchus-associated lymphoid tissue in rheumatoid arthritis. Am J Respir Crit Care Med 1996; 154:1903-1907.
44. Walters MN, Ojeda VJ. Pleuropulmonary necrobiotic rheumatoid nodules. A review and clinicopathological study of six patients. Med J Aust 1986; 144:648-651.
45. Gonzalez-Lopez L, Rocha-Munõz AD, Ponce-Guarneros M, et al. Anticyclic citrullinated peptide (anti-CCP) and antimutated citrullinated vimentin (anti-MCV) relation with extra-articular manifestations in rheumatoid arthritis. J Immunol Res 2014; 2014:536050.
46. Schreiber J, Koschel D, Kekow J, et al. Rheumatoid pneumoconiosis (Caplan's syndrome). Eur J Intern Med 2010; 21:168-172.
47. Macfarlane JD, Dieppe PA, Rigden BG, et al. Pulmonary and pleural lesions in rheumatoid disease. Br J Dis chest 1978; 72:288-300.
48. Voskuyl AE, Hazes JM, Zwinderman AH, et al. Diagnostic strategy for the assessment of rheumatoid vasculitis. Ann Rheum Dis 2003; 62: 407-413.
49. Aho K, Heliövaara M, Maatela J, et al. Rheumatoid factors antedating clinical rheumatoid arthritis. J Rheumatol 1991; 18:1282-1284.
50. Kurki P, Aho K, Palosuo T, Heliövaara M. Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede the clinical disease. Arthritis Rheum 1992; 35:914-917.
51. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003; 48:2741-2749.
52. Nielen MM, van Schaardenburg D, ReesinkHW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50:380-386.
53. Chibnik LB, Mandl LA, Costenbader KH, et al. Comparison of threshold cutpoints and continuous measures of anticyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis. J Rheumatol 2009; 36: 706-711.
54. Majka DS, Deane KD, Parrish LA, et al. Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis. Ann Rheum Dis 2008; 67:801-807.
55. Shi J, van de Stadt LA, Levarht EW, et al. Anticarbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann Rheum Dis 2014; 73:780-783.
56. Vossenaar ER, Smeets TJ, Kraan MC, et al. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 2004; 50:3485-3494.
57. Makrygiannakis D, Hermansson M, Ulfgren AK, et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008; 67: 1488-1492.
58. Reynisdottir G, Karimi R, Joshua V, et al. Structural changes and antibody enrichment in the lungs are early features of anticitrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol 2014; 66:31-39.
59. Lugli EB, Correia R, Fischer R, et al. Expression of citrulline and homocitrulline residues in the lungs of nonsmokers and smokers: implications for autoim-munity in rheumatoid arthritis. Arthritis Res Ther 2015; 17:9.
60. Demoruelle MK, Weisman MH, Simonian PL, et al. Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum 2012; 64:1756-1761.
61. Willis VC, Demoruelle MK, Derber LA, et al. Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum 2013; 65:2545-2554.
62. Perry E, Stenton C, Kelly C, et al. RA autoantibodies as predictors of rheumatoid arthritis in noncystic fibrosis bronchiectasis patients. Eur Respir J 2014; 44:1082-1085.
63. Janssen KM, de Smit MJ, Brouwer E, et al. Rheumatoid arthritis-associated autoantibodies in nonrheumatoid arthritis patients with mucosal inflammation: a case-control study. Arthritis Res Ther 2015; 17:174.
64. Ytterberg AJ, Joshua V, Reynisdottir G, et al. Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation. Ann Rheum Dis 2015; 74:1772-1777.
65. Joshua V, Reynisdottir G, Ytterberg J, et al. Characterization of lung inflam mation and identification of shared citrullinated targets in the lungs and joints of early RA. Arthritis Rheum 2013; 65:S392-S492.
66. Fischer A, Solomon JJ, du Bois RM, et al. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med 2012; 106:1040-1047.